# EVDI
> **NDA220837** · New Drug Application · Sponsor: APOTEX · Approved 2026-05-01
## Drug
- **FDA Application Number:** NDA220837
- **Application type:** New Drug Application
- **Brand name:** EVDI
- **Generic name:** Trabectedin
- **Active ingredients:** TRABECTEDIN
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** APOTEX
- **First approval:** 2026-05-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220837)
---
*AI Analytics · CC0 1.0*